Canada withdraws a batch of H1N1 vaccine because of its adverse effect

Canada withdraws a batch of H1N1 vaccine and its adverse effect
M. R. S. - Madrid - 25/11/2009
 VoteResult No interésPoco interesanteDe interésMuy interesanteImprescindible 8 votesPrint Send
Canadian health authorities have crippled the administration of a consignment of 172,000 doses of vaccine against swine flu after severe allergic reactions were registered in six people who had received. Public Health Agency of Canada will now analyze what could have happened to the implicated batch of Arepanrix, adjuvanted preparation of GlaxoSmithKline.

      Canada
      Canada
      DEPTH

      Capital:
          Ottawa.

      Government:
          Parliamentary Confederation.

      Population:
          33,212,696 (est. 2008)
The news on other sites

    * Websites in Spanish
    * In other languages
"Ending the use of a batch of vaccines as a precaution it is not unusual," he said yesterday a spokeswoman for the Canadian health agency. In this case the removal of the lot has been done, he said, because they have detected more than the usual allergic reactions. However, the six affected have recovered.
The measure of Canadian authorities affects only that batch of 172,000 immunizations distributed in several regions. "People have already been vaccinated and have not had any side effects should not worry. The H1N1 vaccine is safe and very effective," said agency spokesman.
A lab spokesman has clarified that the lot was distributed only in Canada, currently under investigation with health authorities the reason for the appearance of the six allergic reactions confined to the lot.
In Canada have so far distributed 7.5 million doses of vaccine from GlaxoSmithKline, as confirmed by the laboratory. The U.S. has been particularly affected by the pandemic. Authorities say the epidemic has not peaked.

Escuchar

Leer fonéticamente